Skip to main content
KROS logo

KROS · Keros Therapeutics, Inc. · Options Chain

Track KROS — free
$11.31 +0.14 (+1.25%) At close · Sep 9
Market Cap
$224.44M
Shares
19.83M

Options Chain

Underlying $11.31 · at close Sep 9, 2026 Options Calculator

Positioning

Sep 18, 2026 · 8 days to expiry · 24 contracts · mixed daily-bar sessions · Jan 22, 2026–Sep 8, 2026; 12 unknown
Put / call OI
3.71
Put-heavy positioning
Open interest
405
as of Sep 8, 2026
Volume
dated and unknown daily-bar sessions
Max pain
$12.50
$1.19 above spot
ATM implied vol
454.1%
market's expected move

Open interest by strike

Calls Puts

Chain

Click any strike for greeks, breakeven and the calculator
OI Vol IV Δ Bid Ask Last Strike Last Bid Ask Δ IV Vol OI
$7.00 $11.40 $0.00 $4.90
5 2 $4.50 $6.80 $6.00 $0.00 $0.15
$2.00 $6.40 $0.00 $0.25
19 2 205.3% 0.712 $0.10 $4.00 $1.31 $0.23 $0.00 $0.15 181 210
18 31 454.1% 0.575 $0.25 $4.90 $0.40 $2.25 $0.00 $3.10 92 95
8 1 $0.00 $2.55 $0.45 $1.20 $5.50 1
4 1 $0.00 $4.90 $0.55 $2.70 $3.70 $8.00 1
23 15 $0.00 $4.90 $0.75 $6.15 $6.20 $10.50 6 10
1 $0.00 $4.90 $8.70 $13.00 3
1 1 $0.00 $4.90 $2.10 $11.20 $15.50
1 $0.00 $4.90 $16.20 $20.50
6 2 $0.00 $0.95 $0.55 $21.20 $25.50
About this data

Each contract's last price, day range and volume belong to the daily-bar session shown in its details; unknown means the source omitted that timestamp. Open interest has its own effective date shown separately; implied volatility and greeks are model values computed when fetched. This chain has mixed daily-bar sessions · Jan 22, 2026–Sep 8, 2026; 12 unknown. Positioning totals are shown only when every returned open-interest value has the same known effective date. Bid and ask are real-time consolidated OPRA readings.

In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.

Key facts CIK 1664710 CUSIP 492327101 13F (30d) 94 filings 94 filers Visit website Investor relations